
--- Page 1 ---
Ics-0-3 Csrtinons,unfi1trating ouct, Nos 85oof3 1/211 Procedure Date. Procedure Physician. Attending Physician/Copies To: UUID:E66D3DF8-1605-4EFD-AAFA-74F82366FD16 TCGA-BH-A1ET-01A-PR Redacted PATIeNT HISTORy: * DATE of LMP: * DATE OF LAST DELIVERY: * PRE-OP DIAGNOSIS: CANCER LEFT BREASTS POST-OP DIAGNOSIS: SAME OPERATIVE PROCEDURE: LEFT SEGMENTAL MAST, LEFT AXILLARY DISS CLINICAL HISTORY: MATERIAL SUEMITTED: A)(LEFT BREAST BIOPSY/MASS/SEGMENTAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE B) LEFT AXILLARY LYMPH NODE(S), PROCUREMENT BY SURGICAL PROCEDURE ADDENDA: Addendum MACROSCOPIC"DrsCRIDTION: BloCk "A2" for ER/PR and HER-2/neu FINAL DIAGNOSIS: ER/PR RESULTS IMMUNOPEROXIDASE IDENTIFICATION OF ESTROGEN AND PROCESTERONE RECEPTORS IS CARRIED OUT ON SLIDE "A2". DISTINCT INTRANUCLEAR STAINING IS IDENTIFIED FOR ESTROGEN RECEPTOR (95t) AND PROGESTERONE RECEPTOR (SOt). THEREFORE, BOTH ARE INTRRPRETED AS POSITIVE.S HER-2/NBU RESULTS AS PER THE REQUEST OF DR. BAFFONI, c-erbB2 (HER-2/NEU) IMUNOSTAINING IS CARRIED OUT ON PREVIOUS MAGEE r BLOCK "A2" (BREAST CANCER) USING A 1:3OO DILUTION Or DAKO'S POLYCLCNAL ANTIBODY A485 (DIRECTED AGAINST THE INTRACELLULAR DOMAIN OF C-erbB2) WITHOUT ANTIGEN RETRIEVAL. NO DISTINCT COMPLETE MEMSRANE STAININC IS IDENTIPIED. THERSFORE, C-erbB2 (HXR-2/NEU) IS INTERPRETED AS NEGATIVE (SCORE O). FINAL DIAGNOSIS: FINAL DIAGNOSIS: A) LEFT SREAST, SEQMENTAL MASTECTOMY: INFILTRATING MODERATELY DIFFERENTIATED DUCT CARCINOMA NITH FOCAL LORINAR FEATURES. 2.O CM. (AS MEASURED ON GLASS SLIDE),.. .POOR ARCHITECTURAL GRADE,. INTERMEDIATED NUCLEAR GRADE (NOTTINGHAN SCORE-6, TUBULES-3, MITOTIC RATE-1, NUCLEAR PLEOMORPHISM-2) (SEE NOTE) (CROSS REFER A - FIBROCYSTIC CHANGES WITH ATYPICAL DUCTAL EPITHELIAL HYPERPLASIA PAPILLOMATOSIS WITH ASSOCIATED MICROCALCIFICATIONSS - MARGINS OF RESECTION ARE FREE OF TUMORS B) LEFT AXILLARY CONTENTS:  ONE OF NINETEEN (L/19) LYNPH NODES POSITIVE FOR METASTATIC CARCINOMA